Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory, Randomised, Parallel Group Study, Comparing the Protective Effect of Soluble Beta-1,3/1,6-Glucan or Placebo in Oral Mucositis in Head and Neck Cancer Patients Receiving Radiation Therapy or Chemoradiotherapy

NCT00289003 is registered in ClinicalTrials.gov with Biotec Pharmacon ASA as lead sponsor.

NCT NCT00289003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00289003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory, Randomised, Parallel Group Study, Comparing the Protective Effect of Soluble Beta-1,3/1,6-Glucan or Placebo in Oral Mucositis in Head and Neck Cancer Patients Receiving Radiation Therapy or Chemoradiotherapy
Lead sponsor
Biotec Pharmacon ASA
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2003
Completion date
July 31, 2006
Enrollment
40
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

oral mucositis